Top Industry Leaders in the Diabetic Ulcer Treatment Market
Latest Diabetic Ulcer Treatment Companies Update:
Acelity Acquires Systagenix Acelity, a leading wound care specialist, recently acquired Systagenix, a developer of advanced wound dressings. This acquisition strengthens Acelity's portfolio and expands its reach in the diabetic ulcer treatment market.
Coloplast Expands its Biologic Offerings Coloplast, another major player, announced the launch of a new bioengineered skin substitute specifically designed for diabetic foot ulcers. This highlights the growing emphasis on regenerative medicine solutions.
Small Players Making Strides Smaller companies like Molnlycke Health Care and Organogenesis Inc. are also making significant contributions. Molnlycke recently received FDA approval for its new alginate dressing, while Organogenesis continues to develop novel growth factors for wound healing.
List of Diabetic Ulcer Treatment Key companies in the market
-
Smith & Nephew PLC (UK)
-
Integra LifeSciences Corporation (US)
-
SANUWAVE Health
-
Cardinal Health (US)
-
3M (US)
-
Braun Melsungen AG (Germany)
-
ACELITY L.P. INC. (US)